Australian Broker Call

Morgans rates ANZ as Hold (3) -

Morgans believes the bank's decision to reduce the institutional and international capital is the right move but observes the market is over-stating the potential upside. Execution risks remain high.

The broker contends it is not widely acknowledged that ANZ still has a price to pay for past mistakes and this will likely be in the form of significantly lower cumulative tangible book value-per-share growth relative to major bank peers.

The broker refines earnings forecasts in light of a detailed analysis of the strategy and retains a Hold rating, raising the target to $24.00 from $22.50.

Target price is $24.00 Current Price is $27.24 Difference: minus $3.24 (current price is over target).
If ANZ meets the Morgans target it will return approximately minus 12% (excluding dividends, fees and charges - negative figures indicate an expected loss).

Current consensus price target is $28.22, suggesting upside of 3.2% (ex-dividends)

The company's fiscal year ends in September.

Forecast for FY16:

Forecast for FY17:

Market Sentiment: 0.4

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

Macquarie rates BHP as Outperform (1) -

BHP Billiton has unsurprisingly cut its US shale reserves following delays to further drilling. Reserve offsets nevertheless come from Aust coal and Chilean copper, as well as Olympic Dam. The surge in coal prices has transformed BHP's earnings outlook, the broker notes.

The broker believes the company is entering a strong FY17 earnings upgrade cycle and has set its forecast 40% above consensus. Were current spot prices to be applied this number would rise to 85%.

Outperform retained, target rises to $25 from $24.

Target price is $25.00 Current Price is $20.72 Difference: $4.28
If BHP meets the Macquarie target it will return approximately 21% (excluding dividends, fees and charges).

Current consensus price target is $23.04, suggesting upside of 8.6% (ex-dividends)

The company's fiscal year ends in June.

Forecast for FY17:

Forecast for FY18:

This company reports in USD. All estimates have been converted into AUD by FNArena at present FX values.

Market Sentiment: 0.6

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

Credit Suisse rates CAR as Upgrade to Outperform from Neutral (1) -

The company continues to innovate and improve monetisation, Credit Suisse observes. The broker considers the offshore opportunity is long term and does not factor in significant upside in valuation.

The stock is upgraded to Outperform from Neutral, given the pull back in the share price. Target is steady at $12.50.

Target price is $12.50 Current Price is $11.64 Difference: $0.86
If CAR meets the Credit Suisse target it will return approximately 7% (excluding dividends, fees and charges).

Current consensus price target is $12.11, suggesting upside of 0.7% (ex-dividends)

The company's fiscal year ends in June.

Forecast for FY17:

Forecast for FY18:

Market Sentiment: 0.3

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

Macquarie rates CCL as Underperform (5) -

Container deposit schemes are being proposed in NSW, Qld and WA to add to exiting schemes in SA and NT. If implemented, the cost would thus be imposed on a further 65% of the population, the broker notes.

With fizzy drink volumes already declining, the broker believes the impact on Coke earnings will be potentially material. The company has a solid balance sheet and offers a reasonable yield but is overpriced in the broker's view. Underperform and $8.84 target retained.

Target price is $8.84 Current Price is $10.03 Difference: minus $1.19 (current price is over target).
If CCL meets the Macquarie target it will return approximately minus 12% (excluding dividends, fees and charges - negative figures indicate an expected loss).

Current consensus price target is $9.51, suggesting downside of -5.3% (ex-dividends)

The company's fiscal year ends in December.

Forecast for FY16:

Forecast for FY17:

Market Sentiment: 0.1

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

Macquarie rates CHC as Outperform (1) -

Charter Hall will create a new wholesale shopping centre fund, the Charter Hall Prime Retail Fund, and has also acquired 50% of Coles' head office in Melbourne. The first acquisition for the CPRF will be Campbelltown Mall in Sydney.

The broker sees the CPRF as around 2% earnings accretive but has not yet factored in the Coles HQ stake given uncertainty around the holding structure. Outperform retained, target rises to $5.68 from $5.65.

Target price is $5.68 Current Price is $5.38 Difference: $0.3
If CHC meets the Macquarie target it will return approximately 6% (excluding dividends, fees and charges).

Current consensus price target is $5.21, suggesting downside of -3.1% (ex-dividends)

The company's fiscal year ends in June.

Forecast for FY17:

Forecast for FY18:

Market Sentiment: 0.0

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

Credit Suisse rates GNC as Outperform (1) -

Credit Suisse upgrades crop production estimates for FY17, but notes that recent rain across east coast regions has increased the risk of crop damage.

Storage and logistics account for $11m of the $12m EBIT upgrade. Outperform rating and $9 target retained.

Target price is $9.00 Current Price is $7.82 Difference: $1.18
If GNC meets the Credit Suisse target it will return approximately 15% (excluding dividends, fees and charges).

Current consensus price target is $8.92, suggesting upside of 12.6% (ex-dividends)

The company's fiscal year ends in September.

Forecast for FY16:

Forecast for FY17:

Market Sentiment: 0.6

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

Macquarie rates GPT as Upgrade to Neutral from Underperform (3) -

The result of Macquarie's attendance at a breakfast hosted by GPT is an upgrade to Neutral. However it's not about the Eggs Benedict.

GPT shares fell 10% in the June quarter when the REIT sector fell 2.5%, Macquarie notes. While the growth profile is still expected to slow in FY17, the stock is now offering an 11% total shareholder return on the broker's numbers. Hence the upgrade. Target unchanged at $5.16.

Target price is $5.16 Current Price is $4.86 Difference: $0.3
If GPT meets the Macquarie target it will return approximately 6% (excluding dividends, fees and charges).

Current consensus price target is $5.07, suggesting upside of 3.7% (ex-dividends)

The company's fiscal year ends in December.

Forecast for FY16:

Forecast for FY17:

Market Sentiment: -0.3

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

Credit Suisse rates KMD as Neutral (3) -

FY16 results were solid and in line and Credit Suisse also notes a significant improvement in per-store inventory. This drove an improvement in cash flow and, as a result, net debt.

The broker observes a degree of self help is being undertaken to improve operations but FX headwinds and a competitive environment are likely to offset the gains.

Target price is NZ$1.98. Neutral rating retained.

Current Price is $1.96. Target price not assessed.

Current consensus price target is $1.91, suggesting downside of -1.1% (ex-dividends)

The company's fiscal year ends in July.

Forecast for FY17:

Forecast for FY18:

This company reports in NZD. All estimates have been converted into AUD by FNArena at present FX values.

Market Sentiment: 0.4

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

Deutsche Bank rates KMD as Buy (1) -

FY16 results were largely in line with guidance, with gross margin expansion of 70 basis points in Australia considered the highlight. Deutsche Bank is more confident that the earnings recovery is high quality and not reflecting cost control alone.

The broker believes management has a credible strategy for pursuing low-risk offshore expansion. Buy rating retained. Target rises to NZ$2.25 from NZ$2.10.

Current Price is $1.96. Target price not assessed.

Current consensus price target is $1.91, suggesting downside of -1.1% (ex-dividends)

The company's fiscal year ends in July.

Forecast for FY17:

Forecast for FY18:

This company reports in NZD. All estimates have been converted into AUD by FNArena at present FX values.

Market Sentiment: 0.4

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

Macquarie rates KMD as Outperform (1) -

Kathmandu's profit result and dividend beat the broker. There were otherwise no real surprises given the August update, although earnings were driven by improved margins and reduced costs on subdued sales growth. The trick now is to improve sales, the broker suggests.

The first half earnings result will be challenged by strong comparables last year and FX headwinds, the broker notes. But this appears more than captured in the current price, hence the broker retains Outperform. Target rises to $2.20 from $1.70.

Target price is $2.20 Current Price is $1.96 Difference: $0.24
If KMD meets the Macquarie target it will return approximately 12% (excluding dividends, fees and charges).

Current consensus price target is $1.91, suggesting downside of -1.1% (ex-dividends)

The company's fiscal year ends in July.

Forecast for FY17:

Forecast for FY18:

This company reports in NZD. All estimates have been converted into AUD by FNArena at present FX values.

Market Sentiment: 0.4

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

Morgan Stanley rates KMD as Equal-weight (3) -

FY16 results were driven by a strong improvement in gross margin but Morgan Stanley expects growth to moderate in FY17 because of currency headwinds and less opportunity for cost reductions in the near term.

The broker retains an Equal-weight rating and expects the offshore expansion being unproven will take time to execute. Target is raised to $1.90 from $1.50. Industry view is In-Line.

Target price is $1.90 Current Price is $1.96 Difference: minus $0.06 (current price is over target).
If KMD meets the Morgan Stanley target it will return approximately minus 3% (excluding dividends, fees and charges - negative figures indicate an expected loss).

Current consensus price target is $1.91, suggesting downside of -1.1% (ex-dividends)

The company's fiscal year ends in July.

Forecast for FY17:

Forecast for FY18:

This company reports in NZD. All estimates have been converted into AUD by FNArena at present FX values.

Market Sentiment: 0.4

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

Macquarie rates MNS as Initiation of coverage with Outperform (1) -

The broker has initiated coverage of Magnis Resources with an Outperform rating and $1.70 target. The company boasts a graphite resource of exceptional purity at its Nachu project in Tanzania which, unlike most graphite sources, will require limited purification.

Pricing remains a risk, given graphite is now swept up in the new technology market with Lithium batteries only one use. This will mean Magnis will be beholden to the supply-demand swings and roundabouts being experienced in these commodities at present, the broker warns

Target price is $1.70 Current Price is $0.90 Difference: $0.805
If MNS meets the Macquarie target it will return approximately 90% (excluding dividends, fees and charges).

Market Sentiment: 1.0

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

Citi rates NUF as Neutral (3) -

Citi saw Nufarm releasing a financial report meeting or exceeding all the key targets, so it was "strong". The analysts lifted EBIT forecasts but with no impact on net profit estimates due to higher FX hedging and interest expenses.

Citi analysts note management's Get Fit program is ahead of schedule and believe the combination of ongoing progress in Latam, favorable early seasonal conditions in Australia and self-help sets Nufarm up for another year of "solid growth". Neutral rating retained. Price target jumps to $8.95 from $8.05.

Target price is $8.95 Current Price is $8.71 Difference: $0.24
If NUF meets the Citi target it will return approximately 3% (excluding dividends, fees and charges).

Current consensus price target is $9.02, suggesting upside of 0.1% (ex-dividends)

The company's fiscal year ends in July.

Forecast for FY17:

Forecast for FY18:

Market Sentiment: 0.4

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

Credit Suisse rates NUF as Upgrade to Outperform from Neutral (1) -

FY16 results surpassed expectations with cost savings ahead of schedule. Credit Suisse upgrades earnings estimates and believes the stock's growth profile now supports an upgrade in rating to Outperform from Neutral.

Industry consolidation is also expected to create an opportunity for Nufarm. The broker adds $1 a share of value and assumes Nufarm can acquire an asset at good value, with management expecting a deal could take 12-18 months. Target rises to $9.70 from $8.20.

Target price is $9.70 Current Price is $8.71 Difference: $0.99
If NUF meets the Credit Suisse target it will return approximately 11% (excluding dividends, fees and charges).

Current consensus price target is $9.02, suggesting upside of 0.1% (ex-dividends)

The company's fiscal year ends in July.

Forecast for FY17:

Forecast for FY18:

Market Sentiment: 0.4

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

Deutsche Bank rates NUF as Sell (5) -

FY16 results were mixed with underlying net profit broadly in line with expectations but operating cash flow 17% below.

Deutsche Bank reduces earnings forecasts by 4-10% to reflect the net impact of lower earnings in Australia, Europe and seeds, partly offset by higher earnings in South and North America and Asia.

The broker retains a Sell rating and $6.25 target.

Target price is $6.25 Current Price is $8.71 Difference: minus $2.46 (current price is over target).
If NUF meets the Deutsche Bank target it will return approximately minus 28% (excluding dividends, fees and charges - negative figures indicate an expected loss).

Current consensus price target is $9.02, suggesting upside of 0.1% (ex-dividends)

The company's fiscal year ends in July.

Forecast for FY17:

Forecast for FY18:

Market Sentiment: 0.4

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

Macquarie rates NUF as Outperform (1) -

Nufarm's profit fell short of the broker but was ahead of consensus. Underlying earnings were solid and ahead of the broker, thanks to better than expected cost reductions and a good performance in South America.

A strong FY17 is expected as cost cuts continue, pressure on A&NZ volumes and margins reverses and finance cost pressures begin to moderate. Outperform retained, target rises to $9.50 from $8.95.

Target price is $9.50 Current Price is $8.71 Difference: $0.79
If NUF meets the Macquarie target it will return approximately 9% (excluding dividends, fees and charges).

Current consensus price target is $9.02, suggesting upside of 0.1% (ex-dividends)

The company's fiscal year ends in July.

Forecast for FY17:

Forecast for FY18:

Market Sentiment: 0.4

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

Morgans rates NUF as Upgrade to Add from Hold (1) -

FY16 results were ahead of estimates but the Australian result disappointed Morgans. The broker expects the company will benefit from the first decent summer cropping season in Australia for four years and South America is set for a bigger season.

The broker believes the stock now has a much stronger growth profile and through internal improvements is intent on lifting returns to shareholders over time.

The broker considers the stock attractively priced for its growth profile and upgrades to Add from Hold. Target rises to $9.65 from $8.60.

Target price is $9.65 Current Price is $8.71 Difference: $0.94
If NUF meets the Morgans target it will return approximately 11% (excluding dividends, fees and charges).

Current consensus price target is $9.02, suggesting upside of 0.1% (ex-dividends)

The company's fiscal year ends in July.

Forecast for FY17:

Forecast for FY18:

Market Sentiment: 0.4

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

Ord Minnett rates NUF as Hold (3) -

FY16 results were ahead of Ord Minnett's estimates.  Management remains confident it can deliver the balance of the benefits from its performance improvement program.

The broker notes the operating earnings and margins of the Latin American business improved substantially but the operating environment has been costly.

Nufarm has intentionally focused on its higher margin products in Australasia and this has resulted in earnings being affected by low fixed cost recoveries.

It seems to the broker the balance needs to be fine tuned to lift utilisation rates and ensure profitability is maximised. Ord Minnett retains a Hold rating and raises the target to $9.10 from $8.20.

Target price is $9.10 Current Price is $8.71 Difference: $0.39
If NUF meets the Ord Minnett target it will return approximately 4% (excluding dividends, fees and charges).

Current consensus price target is $9.02, suggesting upside of 0.1% (ex-dividends)

The company's fiscal year ends in July.

Forecast for FY17:

Forecast for FY18:

Market Sentiment: 0.4

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

UBS rates NUF as Buy (1) -

UBS considers the FY16 result credible in tough conditions. Cost saving initiatives were better than expected.

The broker considers the reduced costs and cash flow conversion as mostly sustainable, which underpins the re-rating over the past 12 months.

The broker retains a Buy rating and raises the target to $10.00 from $8.50.

Target price is $10.00 Current Price is $8.71 Difference: $1.29
If NUF meets the UBS target it will return approximately 15% (excluding dividends, fees and charges).

Current consensus price target is $9.02, suggesting upside of 0.1% (ex-dividends)

The company's fiscal year ends in July.

Forecast for FY17:

Forecast for FY18:

Market Sentiment: 0.4

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

Macquarie rates OFX as Downgrade to Neutral from Outperform (3) -

Macquarie still sees Ozforex' "Accelerate" target of doubling revenues by 2019 as ambitious and offering risk, while offering significant upside if achieved. The problem is that outside of GBP, volatility has been subsiding in currency markets, the broker notes, and this will make the job more difficult.

On that basis Macquarie has cut its target to $2.30 from $2.60 and downgraded to Neutral.

Target price is $2.30 Current Price is $2.11 Difference: $0.19
If OFX meets the Macquarie target it will return approximately 9% (excluding dividends, fees and charges).

The company's fiscal year ends in March.

Forecast for FY17:

Forecast for FY18:

Market Sentiment: 0.5

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

Macquarie rates ORG as Outperform (1) -

Origin Energy has announced a change of management but not a change of structure. This means there will be no demerger of up/downstream businesses just yet, and thus investors are stuck with the worst of both worlds, the broker suggests.

The new management team is expected to address the demerger issue again in 12 months. In the meantime the focus is on debt reduction through non-core asset divestment. The broker retains Outperform. Target falls to $5.83 from $6.37.

Target price is $5.83 Current Price is $4.87 Difference: $0.96
If ORG meets the Macquarie target it will return approximately 20% (excluding dividends, fees and charges).

Current consensus price target is $6.09, suggesting upside of 21.3% (ex-dividends)

The company's fiscal year ends in June.

Forecast for FY17:

Forecast for FY18:

Market Sentiment: 0.6

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

Citi rates QUB as Buy (1) -

Citi sees the A3 contract loss as further evidence new management of Patrick needs to deliver improvements in operational performance that improve service levels to customers. They believe pricing pressure at Patrick will only increase.

Having said so, Citi's positive view for the years ahead seems to be built on the Moorebank project. Estimates have been reduced on average by 2.8% over FY17-FY19. Price target falls to $2.86 (was $2.98). Buy.

Target price is $2.86 Current Price is $2.28 Difference: $0.58
If QUB meets the Citi target it will return approximately 25% (excluding dividends, fees and charges).

Current consensus price target is $2.66, suggesting upside of 16.7% (ex-dividends)

The company's fiscal year ends in June.

Forecast for FY17:

Forecast for FY18:

Market Sentiment: 0.3

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

Morgans rates S32 as Downgrade to Hold from Add (3) -

The stock is leveraged to rising coal and manganese prices which support estimates and Morgans increases forecasts but considers the upside for the stock is reduced because of the surge in the share price.

Morgans downgrades to Hold from Add and lifts the target to $2.52 from $2.42, preferring to wait to accumulate on weakness.

Target price is $2.52 Current Price is $2.38 Difference: $0.14
If S32 meets the Morgans target it will return approximately 6% (excluding dividends, fees and charges).

Current consensus price target is $2.24, suggesting downside of -5.9% (ex-dividends)

The company's fiscal year ends in June.

Forecast for FY17:

Forecast for FY18:

This company reports in USD. All estimates have been converted into AUD by FNArena at present FX values.

Market Sentiment: 0.3

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

Morgans rates SFR as Downgrade to Hold from Add (3) -

Higher long-term gold prices have partly offset lower near-term copper price assumptions, resulting in a slight reduction in  the valuation and this forces Morgans to downgrade to Hold from Add.

The broker prefers to sit out any volatility in US dollar commodities post the upcoming US Federal Reserve decision on rates on September 21. Target is reduced to $5.91 from $6.05.

Target price is $5.91 Current Price is $5.42 Difference: $0.49
If SFR meets the Morgans target it will return approximately 9% (excluding dividends, fees and charges).

Current consensus price target is $5.71, suggesting upside of 4.9% (ex-dividends)

The company's fiscal year ends in June.

Forecast for FY17:

Forecast for FY18:

Market Sentiment: 0.1

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

Citi rates SGM as Buy (1) -

Citi analysts note management has announced the sale of two metal recycling facilities in Detroit and Toledo, which is consistent with the strategy of divestment of non-core assets.

According to the analysts, this now leaves just three small facilities out five underperforming assets to be dealt with in FY17. Citi analysts grab the opportunity to highlight their expectations are 22% ahead of consensus. Buy. Target $11.20.

Citi analysts remain of the view that market consensus will be chasing upgrades through 1H17.

Target price is $11.20 Current Price is $9.00 Difference: $2.2
If SGM meets the Citi target it will return approximately 24% (excluding dividends, fees and charges).

Current consensus price target is $9.55, suggesting upside of 2.2% (ex-dividends)

The company's fiscal year ends in June.

Forecast for FY17:

Forecast for FY18:

Market Sentiment: 0.0

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

Credit Suisse rates SGM as Neutral (3) -

The company has sold two North American facilities and has largely completed its exit from the loss-making central region.

Credit Suisse notes scrap prices have weakened recently, reflecting lower steel prices and weaker demand.

The broker suspects the recent US re-bar anti-dumping initiatives could increase domestic demand and potentially reduce the scrap available for the company's export facing business.

Neutral rating and $9.30 target retained.

Target price is $9.30 Current Price is $9.00 Difference: $0.3
If SGM meets the Credit Suisse target it will return approximately 3% (excluding dividends, fees and charges).

Current consensus price target is $9.55, suggesting upside of 2.2% (ex-dividends)

The company's fiscal year ends in June.

Forecast for FY17:

Forecast for FY18:

Market Sentiment: 0.0

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

Deutsche Bank rates SGM as Sell (5) -

The company has sold two metal recycling facilities in North America. The terms have not been disclosed. Deutsche Bank believes two facilities remain to be divested or closed.

The balance sheet is robust and the broker considers the sales provide further evidence that management is making progress on its strategy but that the industry structure is not supporting rational behaviour.

Deutsche Bank retains a Sell rating. Target is $8.02.

Target price is $8.02 Current Price is $9.00 Difference: minus $0.98 (current price is over target).
If SGM meets the Deutsche Bank target it will return approximately minus 11% (excluding dividends, fees and charges - negative figures indicate an expected loss).

Current consensus price target is $9.55, suggesting upside of 2.2% (ex-dividends)

The company's fiscal year ends in June.

Forecast for FY17:

Forecast for FY18:

Market Sentiment: 0.0

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

Morgan Stanley rates TPM as Overweight (1) -

Morgan Stanley reduces FY17-19 EBITDA estimates by 3-5%. The broker is cognisant of the higher competitive risk in the sector but considers the long-term growth profile is still attractive.

Retail broadband margins are set to start falling in FY17, earlier than the broker initially expected. Overweight rating and In-Line sector view retained. Target is reduced to $10.75 from $11.40.

Target price is $10.75 Current Price is $8.63 Difference: $2.12
If TPM meets the Morgan Stanley target it will return approximately 25% (excluding dividends, fees and charges).

Current consensus price target is $10.23, suggesting upside of 15.7% (ex-dividends)

The company's fiscal year ends in July.

Forecast for FY17:

Forecast for FY18:

Market Sentiment: 0.1

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

Deutsche Bank rates VOC as Buy (1) -

The chief financial officer has resigned but will remain with the company until a successor is chosen. Deutsche Bank does not believe this resignation has been caused by any negative news flow.

The broker envisages strong earnings growth potential as the company stands to benefit from merger synergies. A Buy rating is retained. Target is $12.01.

Target price is $12.01 Current Price is $6.09 Difference: $5.92
If VOC meets the Deutsche Bank target it will return approximately 97% (excluding dividends, fees and charges).

Current consensus price target is $9.40, suggesting upside of 51.1% (ex-dividends)

The company's fiscal year ends in June.

Forecast for FY17:

Forecast for FY18:

Market Sentiment: 0.4

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources